WELCOME TO THE

DELVE BLOG

Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient鈥檚 Lifestyle

鈥擭ot the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020鈥攊mpacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment.

Delve Health Wearable Integrations

At Delve Health, we bring you the power of choice and comprehensive health tracking by integrating with an array of FDA-approved and consumer wearables. Discover

Delve Health 2024 Predictions

2024 Predictions for Clinical Trials

As 2023 draws to a close, it’s crucial to engage in a powerful reflection on the transformative challenges that have swept through the clinical trial

Scroll to Top